Home » Topics » Conferences

Conferences
RSS

Sumitomo proves cardioprotective activity of Na+/H+ exchange inhibitor SM-20550

Aug. 12, 1998

Profile of Solvay's dual NEP/ECE inhibitor in clinical testing

Aug. 12, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

NQ-304, a novel platelet antiaggregatory and antithrombotic agent in early development

Aug. 12, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Dual ETA/ETB antagonist provides effective blood pressure control in rats

Aug. 11, 1998

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Aug. 11, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Aug. 11, 1998

New agents for treating constipation presented at IUPHAR meeting

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026